Moclobemide was found to enhance vitality and energy in patients without notably alleviating depression [187]
Reported side effects are rare and generally mild, most commonly limited to injection site irritation (in the case of CJC-1295/Ipamorelin) or transient scalp sensitivity with topical applications
By delving into the shared characteristics of autism and dyslexia, we deepen our understanding of the complex interplay between these conditions and pave the way for enhanced support, interventions, and advocacy efforts tailored to individuals navigating the unique challenges presented by both disorders
No effects on blood pressure, body weight, BMI, lean mass, fat mass and ratio hip/waist were observed
Food & Drug Administration, Current and Resolved Drug Shortages and Discontinuations Reported to FDA (2025)